BioCardia regains Nasdaq minimum bid-price compliance
BioCardia said it regained compliance with Nasdaq's $1.00 minimum bid-price requirement after 10 consecutive business days at or above $1.00.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
BioCardia said it regained compliance with Nasdaq's $1.00 minimum bid-price requirement after 10 consecutive business days at or above $1.00.